0001819113-23-000034.txt : 20230502
0001819113-23-000034.hdr.sgml : 20230502
20230502162213
ACCESSION NUMBER: 0001819113-23-000034
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230428
FILED AS OF DATE: 20230502
DATE AS OF CHANGE: 20230502
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zaranek Mike
CENTRAL INDEX KEY: 0001886590
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39727
FILM NUMBER: 23879387
MAIL ADDRESS:
STREET 1: C/O LIFESCI ACQUISITION II CORP.
STREET 2: 250 W 55TH STREET, #3401
CITY: NEW YORK
STATE: NY
ZIP: 10019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Science 37 Holdings, Inc.
CENTRAL INDEX KEY: 0001819113
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 844278203
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 800 PARK OFFICES DRIVE
STREET 2: SUITE 3606
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
BUSINESS PHONE: (984) 377-3737
MAIL ADDRESS:
STREET 1: 800 PARK OFFICES DRIVE
STREET 2: SUITE 3606
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
FORMER COMPANY:
FORMER CONFORMED NAME: Lifesci Acquisition II Corp.
DATE OF NAME CHANGE: 20200723
4
1
wf-form4_168305891610313.xml
FORM 4
X0407
4
2023-04-28
0
0001819113
Science 37 Holdings, Inc.
SNCE
0001886590
Zaranek Mike
800 PARK OFFICES DRIVE, SUITE 3606
RESEARCH TRIANGLE PARK
NC
27709
0
1
0
0
Chief Financial Officer
0
Common Stock
2023-04-28
4
A
0
444283
A
444283
D
Stock Option
9.06
2023-04-28
4
D
0
457466
D
2031-06-13
Common Stock
457466.0
0
D
Stock Option
11.47
2023-04-28
4
D
0
185897
D
2032-01-07
Common Stock
185897.0
0
D
Stock Option
10.05
2023-04-28
4
D
0
467351
D
2031-10-07
Common Stock
467351.0
0
D
On April 28, 2023, the issuer cancelled, pursuant to the issuer's option exchange program, options to purchase 457,466 shares of common stock of the issuer and in exchange issued to the reporting person 182,985 restricted stock units, each of which represents a contingent right to receive one share of the issuer's common stock.
On April 28, 2023, the issuer cancelled, pursuant to the issuer's option exchange program, options to purchase 185,897 shares of common stock of the issuer and in exchange issued to the reporting person 74,358 restricted stock units, each of which represents a contingent right to receive one share of the issuer's common stock.
On April 28, 2023, the issuer cancelled, pursuant to the issuer's option exchange program, options to purchase 467,351 shares of common stock of the issuer and in exchange issued to the reporting person 186,940 restricted stock units, each of which represents a contingent right to receive one share of the issuer's common stock.
Includes 444,283 restricted stock units, which will vest in three equal annual installments beginning on April 28, 2024, subject to continued employment.
The total amount has been adjusted to add 11 derivative securities that were not previously included due to a rounding error.
/s/ Christine Pellizzari, Attorney-in-Fact for Mike Zaranek
2023-05-02